362 related articles for article (PubMed ID: 12811247)
1. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154.
Säemann MD; Zeyda M; Diakos C; Szekeres A; Böhmig GA; Kelemen P; Parolini O; Stockinger H; Prieschl EE; Stulnig TM; Baumruker T; Zlabinger GJ
Transplantation; 2003 Jun; 75(11):1864-72. PubMed ID: 12811247
[TBL] [Abstract][Full Text] [Related]
2. Itk, a T cell-specific tyrosine kinase, is required for CD2-mediated interleukin-2 promoter activation in the human T cell line Jurkat.
Tanaka N; Abe H; Yagita H; Okumura K; Nakamura M; Sugamura K
Eur J Immunol; 1997 Apr; 27(4):834-41. PubMed ID: 9130632
[TBL] [Abstract][Full Text] [Related]
3. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
4. T cell activation up-regulates the expression of the focal adhesion kinase Pyk2: opposing roles for the activation of protein kinase C and the increase in intracellular Ca2+.
Tsuchida M; Manthei ER; Alam T; Knechtle SJ; Hamawy MM
J Immunol; 1999 Dec; 163(12):6640-50. PubMed ID: 10586059
[TBL] [Abstract][Full Text] [Related]
5. V7 (CD101) ligation inhibits TCR/CD3-induced IL-2 production by blocking Ca2+ flux and nuclear factor of activated T cell nuclear translocation.
Soares LR; Tsavaler L; Rivas A; Engleman EG
J Immunol; 1998 Jul; 161(1):209-17. PubMed ID: 9647226
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28-induced signalling events: insights into T-cell unresponsiveness in leprosy.
Dagur PK; Sharma B; Kumar G; Khan NA; Katoch VM; Sengupta U; Joshi B
Mol Immunol; 2010 Feb; 47(5):943-52. PubMed ID: 20018378
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the T-cell activation signaling pathway mediated by tyrosine kinases, protein kinase C, and Ras protein, which is modulated by intracellular cyclic AMP.
Ohtsuka T; Kaziro Y; Satoh T
Biochim Biophys Acta; 1996 Feb; 1310(2):223-32. PubMed ID: 8611637
[TBL] [Abstract][Full Text] [Related]
8. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
9. Jak3-regulated genes: DNA array analysis of concanavalin a-interleukin-2-activated chicken T cells treated with a specific jak3 inhibitor.
Kampa D; Burnside J
J Interferon Cytokine Res; 2002 Sep; 22(9):975-80. PubMed ID: 12396719
[TBL] [Abstract][Full Text] [Related]
10. Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells.
Kirken RA; Erwin RA; Taub D; Murphy WJ; Behbod F; Wang L; Pericle F; Farrar WL
J Leukoc Biol; 1999 Jun; 65(6):891-9. PubMed ID: 10380915
[TBL] [Abstract][Full Text] [Related]
11. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
[TBL] [Abstract][Full Text] [Related]
12. Requirement of the Src homology 2 domain protein Shb for T cell receptor-dependent activation of the interleukin-2 gene nuclear factor for activation of T cells element in Jurkat T cells.
Lindholm CK; Gylfe E; Zhang W; Samelson LE; Welsh M
J Biol Chem; 1999 Sep; 274(39):28050-7. PubMed ID: 10488157
[TBL] [Abstract][Full Text] [Related]
13. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.
Whitehurst CE; Geppert TD
J Immunol; 1996 Feb; 156(3):1020-9. PubMed ID: 8557975
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of the T-cell antigen receptor-CD3 complex signaling pathway by the tyrosine phosphatase inhibitor pervanadate is mediated by inhibition of CD45: evidence for two interconnected Lck/Fyn- or zap-70-dependent signaling pathways.
Imbert V; Farahifar D; Auberger P; Mary D; Rossi B; Peyron JF
J Inflamm; 1996; 46(2):65-77. PubMed ID: 8734787
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
Kolenko V; Wang Q; Riedy MC; O'Shea J; Ritz J; Cathcart MK; Rayman P; Tubbs R; Edinger M; Novick A; Bukowski R; Finke J
J Immunol; 1997 Sep; 159(6):3057-67. PubMed ID: 9300731
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line.
Irvin BJ; Williams BL; Nilson AE; Maynor HO; Abraham RT
Mol Cell Biol; 2000 Dec; 20(24):9149-61. PubMed ID: 11094067
[TBL] [Abstract][Full Text] [Related]
17. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
Laxminarayana D; Kammer GM
J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-gamma1 and Ras activation.
Williams BL; Irvin BJ; Sutor SL; Chini CC; Yacyshyn E; Bubeck Wardenburg J; Dalton M; Chan AC; Abraham RT
EMBO J; 1999 Apr; 18(7):1832-44. PubMed ID: 10202147
[TBL] [Abstract][Full Text] [Related]
19. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
Schnaider T; Somogyi J; Csermely P; Szamel M
Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
[TBL] [Abstract][Full Text] [Related]
20. Uncoupling activation-dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28.
Hutchcroft JE; Slavik JM; Lin H; Watanabe T; Bierer BE
J Immunol; 1998 Nov; 161(9):4506-12. PubMed ID: 9794375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
